142 related articles for article (PubMed ID: 38051683)
1. FDA-Approved Drugs to Treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2023 Dec; 61(12):5-6. PubMed ID: 38051683
[No Abstract] [Full Text] [Related]
2. FDA-Approved Drugs to Treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):7-8. PubMed ID: 31774127
[No Abstract] [Full Text] [Related]
3. FDA-Approved Drugs to Treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2021 Dec; 59(12):5-6. PubMed ID: 34846247
[No Abstract] [Full Text] [Related]
4. FDA-Approved Drugs to Treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2020 Dec; 58(12):5-6. PubMed ID: 33238020
[No Abstract] [Full Text] [Related]
5. FDA-Approved Drugs To Treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):11-2. PubMed ID: 23210541
[No Abstract] [Full Text] [Related]
6. FDA-approved drugs to treat schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2014 Dec; 52(12):11-2. PubMed ID: 25453505
[No Abstract] [Full Text] [Related]
7. FDA-approved drugs to treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2013 Dec; 51(12):9-10. PubMed ID: 24305693
[No Abstract] [Full Text] [Related]
8. Asenapine approved for treatment of schizophrenia, bipolar disorder.
Traynor K
Am J Health Syst Pharm; 2009 Sep; 66(18):1596. PubMed ID: 19729558
[No Abstract] [Full Text] [Related]
9. FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
Kuehn BM
JAMA; 2009 Aug; 302(8):833-4. PubMed ID: 19706851
[No Abstract] [Full Text] [Related]
10. Asenapine.
Meltzer HY; Dritselis A; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2009 Nov; 8(11):843-4. PubMed ID: 19876039
[TBL] [Abstract][Full Text] [Related]
11. New schizophrenia drug.
FDA Consum; 2001; 35(3):6. PubMed ID: 11458557
[No Abstract] [Full Text] [Related]
12. FDA-Approved Drugs to Treat Bipolar I and II Disorders.
J Psychosoc Nurs Ment Health Serv; 2024 Jun; 62(6):5-6. PubMed ID: 38838336
[No Abstract] [Full Text] [Related]
13. Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
Wang B; Franklin JM; Eddings W; Landon J; Kesselheim AS
PLoS One; 2016; 11(3):e0152195. PubMed ID: 27032095
[TBL] [Abstract][Full Text] [Related]
14. Studies may not provide clear view of antipsychotics.
Kuehn BM
JAMA; 2012 Apr; 307(15):1572. PubMed ID: 22511673
[No Abstract] [Full Text] [Related]
15. Comparison of the bioequivalence of generic versus branded clozapine.
Ereshefsky L; Glazer WM
J Clin Psychiatry; 2001; 62 Suppl 5():25-7. PubMed ID: 11305845
[No Abstract] [Full Text] [Related]
16. Aripiprazole: An FDA Approved Bioactive Compound to Treat Schizophrenia- A Mini Review.
Kumar A; Singh H; Mishra A; Mishra AK
Curr Drug Discov Technol; 2020; 17(1):23-29. PubMed ID: 30306873
[TBL] [Abstract][Full Text] [Related]
17. Bifeprunox versus placebo for schizophrenia.
Chattopadhyay A; Frey S; Green G
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012029. PubMed ID: 27732740
[TBL] [Abstract][Full Text] [Related]
18. FDA-approved drugs to treat schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2011 Dec; 49(12):11-2. PubMed ID: 22149488
[No Abstract] [Full Text] [Related]
19. Psychopharmacology news.
Silva R
J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):91. PubMed ID: 19232027
[No Abstract] [Full Text] [Related]
20. Introduction: a new era in the pharmacotherapy of psychotic disorders.
Breier A
J Clin Psychiatry; 2001; 62 Suppl 2():3-5. PubMed ID: 11232750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
